Erector Spinae Plane Block in Liver Transplantation Donors

NCT05406388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2023-08-07

No results posted yet for this study

Summary

Living donor liver transplantation has become a common treatment option for patients with end-stage liver disease. Donor hepatectomy is associated with significant postoperative pain due to inverted L-shaped incision. Therefore adequate analgesia is important for recovery.

Erector Spinae Plane Block (ESPB) is a safe anesthesia technique used to provide postoperative analgesia. This study aimed to compare the novel ultrasound-guided ESPB technique with controls in terms of postoperative opioid consumption and postoperative pain control on donor patients.

Conditions

  • Pain, Postoperative

Interventions

PROCEDURE

Erector Spinae Plane Block

Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.

PROCEDURE

Intravenous fentanyl patient control device

Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Principal Investigators

  • Tumay Uludag Yanaral · Medipol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-24
Primary Completion
2023-05-01
Completion
2023-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406388 on ClinicalTrials.gov